RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post The Peptide Gamble: A Doctor's Warning on BPC 157 and TB 500 BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas Holt Law